ArticleEndocrinology, diabetes & metabolism2025
Clinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules-A Retrospective Study.
Article in Endocrinology, diabetes & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules-A Retrospective Study.Endocrinology, diabetes & metabolism · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe appropriate management strategy for patients with thyroid nodules and indeterminate cytology on fine needle aspiration (FNA) remains unclear, especially in centres where molecular testing is not available. In this retrospective study, we aimed to identify factors predicting the risk of malignancy in these patients. MATERIALS AND
methodsThis retrospective study included consecutive patients with thyroid nodules with Bethesda III/IV cytology who underwent surgical management at Hamad Medical Corporation, Qatar, between 01/01/2015 and 30/08/2023. Patients who did not undergo surgical management were excluded. We performed univariate and multivariate logistic regression analysis to assess the factors predicting the risk of malignancy in this population.
resultsOf 449 patients included in the study, the majority were females (72.2%). The mean (SD) age was 43.7 ± 10.7 years. Arab was the most common ethnicity (56.6%), followed by South-Asian (18.9%) and South-East Asian (17.8%). Sonographic features of thyroid nodules were classified as ATA very low in 0.9%, low-risk in 49.1%, intermediate-risk in 42.05% and high-risk in 7.95%. 86.2% had Bethesda III cytology and 13.8% had Bethesda IV cytology. Histopathology of thyroidectomy specimens confirmed malignancy in 179 (39.9%) patients. The malignancy rate in Bethesda III was 37.9%, while in Bethesda IV it was 51.6%. In multivariate logistic regression analysis, ATA intermediate (OR of 1.57 (1.03-2.4); p = 0.03) and high risk (OR of 3.92 (1.81-8.48); p = 0.001) sonographic patterns were predictive of malignancy.
conclusionIn patients with indeterminate thyroid nodule cytology and in the absence of molecular markers, the ATA sonographic pattern of thyroid nodules can guide decision- making for surgical management vs. surveillance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.